Why was Tavist taken off the market? A history of the PPA recall
•
4 min read
In November 2000, the U.S. Food and Drug Administration (FDA) issued a public warning that led to the voluntary recall of dozens of over-the-counter (OTC) medications, including the combination product Tavist-D. This action, which answers the question, 'Why was Tavist taken off the market?', was based on growing evidence that one of its active ingredients, phenylpropanolamine (PPA), could increase the risk of hemorrhagic stroke.
